FDA 510(k) Submission Insights for Syringes

The FDA 510(k) premarket notification process is critical for obtaining market clearance for syringes, including both conventional and Auto Disable (AD) models. This paper provides a comprehensive review of the FDA 510(k) submission requirements for syringes, focusing on the relevant ISO and ASTM standards that govern performance, safety, and biocompatibility. It examines the specific standards applicable to sterile hypodermic syringes, such as ISO 7886-1:2017, 7886-2:2020, ISO 7886-3:2017 and ISO 7886-4:2018, as well as the requirements for sterilization and packaging as outlined by ASTM standards. Additionally, the paper discusses the testing and validation protocols necessary for demonstrating substantial equivalence to predicate devices and addresses challenges and strategies for successful submission. By offering detailed insights into regulatory requirements and compliance strategies, this paper aims to guide manufacturers through the FDA 510(k) process for syringes, ensuring adherence to established standards and facilitating market approval.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Regulatory Affairs
Published
2024-12-15
DOI
https://doi.org/10.22270/ijdra.v12i4.705
Citations
1
Primary Topic
Safe Handling of Antineoplastic Drugs
Type
article
Field-Weighted Citation Impact
1.72
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

FDA 510(k) Submission Insights for Syringes

Harsh Mehta, Chandra Prakash, Akash Sharma, Ankur Vora
1 citations
International Journal of Drug Regulatory Affairs
Safe Handling of Antineoplastic Drugs
1.72
article

FDA 510(k) Submission Insights for Syringes

Harsh Mehta, Chandra Prakash, Akash Sharma, Ankur Vora
article en
1 citations

Abstract

The FDA 510(k) premarket notification process is critical for obtaining market clearance for syringes, including both conventional and Auto Disable (AD) models. This paper provides a comprehensive review of the FDA 510(k) submission requirements for syringes, focusing on the relevant ISO and ASTM standards that govern performance, safety, and biocompatibility. It examines the specific standards applicable to sterile hypodermic syringes, such as ISO 7886-1:2017, 7886-2:2020, ISO 7886-3:2017 and ISO 7886-4:2018, as well as the requirements for sterilization and packaging as outlined by ASTM standards. Additionally, the paper discusses the testing and validation protocols necessary for demonstrating substantial equivalence to predicate devices and addresses challenges and strategies for successful submission. By offering detailed insights into regulatory requirements and compliance strategies, this paper aims to guide manufacturers through the FDA 510(k) process for syringes, ensuring adherence to established standards and facilitating market approval.

International Journal of Drug Regulatory AffairsVol. 12(4)
General Electric (Spain) (ES), KES International (GB)
Openalex Percentile: Top 12%
Safe Handling of Antineoplastic Drugs
1.72
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

FDA 510(k) Submission Insights for Syringes — Harsh Mehta, Chandra Prakash, et al. · International Journal of Drug Regulatory Affairs (2024) | TGRS Research Map | TGRS